Skip to content
OpenCapital
Get started

Charles River Laboratories CRL Q1 2025 earnings

Reported May 7, 2025 · Before market open

Revenue$984.2MBeat by $25.4MDiluted EPS$2.34Beat by $0.28
Revenue estimate$958.8M
EPS estimate$2.06

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$976.1M
EPS estimate$2.72

Financials

Q1 2025

Income statement

See full
Revenue$984.2M-2.7%
Operating income$74.7M-40.7%
Net income$25.5M-65.1%
EPS (diluted)$0.50-61.5%

Balance sheet

See full
Cash & equivalents$231.7M-31.5%
Total debt$3.0B-3.0%
Total equity$3.2B-12.3%
Total assets$7.6B-7.0%

Cash flow

See full
Operating cash flow$171.7M+32.2%
CapEx$59.3M-25.0%
Free cash flow$112.4M+121%

Valuation & ratios

Valuation

as of 03/29/25
See full
Market cap$7.7B-44.7%
Enterprise value$10.48B-37.2%
P/S1.9×-1.5×

Profitability

See full
FCF margin14%+3.9pp

Returns & leverage

See full
Debt / equity0.9×+0.1×
Current ratio1.4×-0.3×

Segments

By segment

See full
DSA$592.6M-2.1%
RMS$213.1M-3.5%
Manufacturing$178.5M-3.6%

By geography

See full
Europe$263.3M-4.7%
Asia Pacific$41.9M-8.4%
Other$16.7M-0.5%

By product

See full
Cost of services provided (excluding amortization of intangible assets)$797.9M-2.3%

Versus estimates

Revenue

Q1 2026$995.8MBeat by $18.4MQ4 2025$994.2MBeat by $7.2MQ3 2025$1.0BBeat by $17.7MQ2 2025$1.0BBeat by $63.2M
Q1 2025$984.2MBeat by $25.4M
Q4 2024$1.0BBeat by $54.3M

Diluted EPS

Q1 2026$2.06Beat by $0.10Q4 2025$2.39Beat by $0.06Q3 2025$2.43Beat by $0.11Q2 2025$3.12Beat by $0.62
Q1 2025$2.34Beat by $0.28
Q4 2024$2.66Beat by $0.16

Ask the moment Charles River Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Charles River Laboratories report Q1 2025 earnings?
Charles River Laboratories (CRL) reported Q1 2025 earnings on May 7, 2025 before market open.
What were Charles River Laboratories's Q1 2025 revenue and EPS?
Charles River Laboratories reported revenue of $984.2M and diluted EPS of $2.34 for Q1 2025.
Did Charles River Laboratories beat estimates in Q1 2025?
Revenue beat the consensus estimate of $958.8M by $25.4M. EPS beat the consensus estimate of $2.06 by $0.28.
How did Charles River Laboratories's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.7% from $1.0B a year earlier and diluted EPS grew 3.1% from $2.27.
Where can I find Charles River Laboratories's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001100682-25-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.